What question did this study set out to answer?

Summarize the current progress and clinical trial landscape of cell therapy approaches used to address impaired osteogenesis in delayed fracture unions and nonunions.

August 2, 2014BoneOpen Access

Bone fracture healing: Cell therapy in delayed unions and nonunions

View Full Paper

Ask AI

Bookmark

Authors

EGEnrique Gómez‐BarrenaThe University of Melbourne PRPhilippe RossetUniversité de Tours DLDaniel LozanoUniversidad Complutense de Madrid

Discussion

Member takes

Implication

Review evaluates cell therapy trials for impaired bone healing in fracture nonunions, highlighting the necessity of clinical evidence to restore osteogenesis.

Key Points

Summarize the current progress and clinical trial landscape of cell therapy approaches used to address impaired osteogenesis in delayed fracture unions and nonunions.
Narrative review evaluating clinical trials focused on cell-based bone healing augmentation.
Analyzed findings from the REBORNE Project alongside investigator-driven clinical trials assessing advanced cellular therapies.
Identified cell therapy as a key strategy to restore deficient osteogenic potential in atrophic nonunions where mechanical stabilization alone is insufficient.
Highlighted the ongoing shortage of robust clinical trials, underscoring the need for further clinical validation to establish safety and efficacy standards.

Cite This Study

Gómez‐Barrena et al. (2014) studied this question.

synapsesocial.com/papers/6a951fcd2dd91e6efbf220e4 https://doi.org/10.1016/j.bone.2014.07.033

View Full Paper

Ask AI

Bookmark

August 2, 2014BoneOpen Access

Bone fracture healing: Cell therapy in delayed unions and nonunions

View Full Paper

Ask AI

Bookmark

Authors

EGEnrique Gómez‐BarrenaThe University of Melbourne PRPhilippe RossetUniversité de Tours DLDaniel LozanoUniversidad Complutense de Madrid

Discussion

Member takes

Implication

Review evaluates cell therapy trials for impaired bone healing in fracture nonunions, highlighting the necessity of clinical evidence to restore osteogenesis.

Key Points

Summarize the current progress and clinical trial landscape of cell therapy approaches used to address impaired osteogenesis in delayed fracture unions and nonunions.
Narrative review evaluating clinical trials focused on cell-based bone healing augmentation.
Analyzed findings from the REBORNE Project alongside investigator-driven clinical trials assessing advanced cellular therapies.
Identified cell therapy as a key strategy to restore deficient osteogenic potential in atrophic nonunions where mechanical stabilization alone is insufficient.
Highlighted the ongoing shortage of robust clinical trials, underscoring the need for further clinical validation to establish safety and efficacy standards.

Cite This Study

Gómez‐Barrena et al. (2014) studied this question.

synapsesocial.com/papers/6a951fcd2dd91e6efbf220e4 https://doi.org/10.1016/j.bone.2014.07.033

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark